Interestingly, CA6, which was validated in our study, was also discovered in this previous proteomic profiling study using saliva samples from non-invasive breast cancer patients (DCIS) [46], indicating the potential of this biomarker for the early detection of breast cancer. This evidence concerns the gene CA6 and breast carcinoma.